These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

390 related items for PubMed ID: 15050083

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL, London J, Heitzmann C, Gibson DR, Morales ES, Dumontet R, Acree M.
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD, Nanda J, Davis-Vogel A, Navaline H, Scotti R, Wickrema R, Metzger D, Sochalski J.
    Public Health Nurs; 2006 Apr; 23(1):11-9. PubMed ID: 16460416
    [Abstract] [Full Text] [Related]

  • 5. Factors associated with client-reported HIV infection among clients entering methadone treatment.
    MacGowan RJ, Fichtner RR, Swanson N, Collier C, Kroliczak A, Cole G.
    AIDS Educ Prev; 1997 Jun; 9(3):205-17. PubMed ID: 9241388
    [Abstract] [Full Text] [Related]

  • 6. Relationship of HIV testing and high-risk behaviors among clients in methadone maintenance treatment.
    Grella CE, Campos M, Anglin MD.
    AIDS Educ Prev; 1998 Oct; 10(5):403-16. PubMed ID: 9799937
    [Abstract] [Full Text] [Related]

  • 7. Methadone maintenance therapy outcomes in Iran.
    Noori R, Narenjiha H, Aghabakhshi H, Habibi G, Khoshkrood Mansoori B.
    Subst Use Misuse; 2012 Jun; 47(7):767-73. PubMed ID: 22416897
    [Abstract] [Full Text] [Related]

  • 8. Changes in HIV risk behaviors among cocaine-using methadone patients.
    Magura S, Rosenblum A, Rodriguez EM.
    J Addict Dis; 1998 Jun; 17(4):71-90. PubMed ID: 9848033
    [Abstract] [Full Text] [Related]

  • 9. Psychosocial antecedents of needle/syringe disinfection by drug users: a theory-based prospective analysis.
    Longshore D, Stein JA, Anglin MD.
    AIDS Educ Prev; 1997 Oct; 9(5):442-59. PubMed ID: 9391659
    [Abstract] [Full Text] [Related]

  • 10. HIV infection as a predictor of methadone maintenance outcomes in Chinese injection drug users.
    Zhao L, Holzemer WL, Johnson M, Tulsky JP, Rose CD.
    AIDS Care; 2012 Oct; 24(2):195-203. PubMed ID: 21780984
    [Abstract] [Full Text] [Related]

  • 11. A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users.
    Margolin A, Avants SK, Warburton LA, Hawkins KA, Shi J.
    Health Psychol; 2003 Mar; 22(2):223-8. PubMed ID: 12683743
    [Abstract] [Full Text] [Related]

  • 12. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, Callaman JM, O'Grady KE, Battjes RJ.
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [Abstract] [Full Text] [Related]

  • 13. Skills-training groups to reduce HIV transmission and drug use among methadone patients.
    Schilling RF, el-Bassel N, Hadden B, Gilbert L.
    Soc Work; 1995 Jan; 40(1):91-101. PubMed ID: 7863377
    [Abstract] [Full Text] [Related]

  • 14. Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users.
    Rodríguez Salgado D, Rodríguez Alvarez M, Seoane Pesqueira G.
    Cogn Behav Neurol; 2006 Jun; 19(2):95-104. PubMed ID: 16783132
    [Abstract] [Full Text] [Related]

  • 15. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM, Petry NM, Stitzer ML, Blaine J, Kellogg S, Satterfield F, Schwartz M, Krasnansky J, Pencer E, Silva-Vazquez L, Kirby KC, Royer-Malvestuto C, Roll JM, Cohen A, Copersino ML, Kolodner K, Li R.
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [Abstract] [Full Text] [Related]

  • 16. Drug injection cessation among HIV-infected injecting drug users.
    Bouhnik AD, Carrieri MP, Rey D, Spire B, Gastaut JA, Gallais H, Obadia Y, MANIF 2000 Study Group.
    Addict Behav; 2004 Aug; 29(6):1189-97. PubMed ID: 15236822
    [Abstract] [Full Text] [Related]

  • 17. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J, Desenclos JC.
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [Abstract] [Full Text] [Related]

  • 18. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
    Razali SM.
    Trop Doct; 2008 Apr; 38(2):109-10. PubMed ID: 18453507
    [Abstract] [Full Text] [Related]

  • 19. Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence.
    Schroeder JR, Epstein DH, Umbricht A, Preston KL.
    Addict Behav; 2006 May; 31(5):868-79. PubMed ID: 16085366
    [Abstract] [Full Text] [Related]

  • 20. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
    Vicknasingam B, Narayanan S, Navaratnam V.
    Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.